A new quadruple therapy for the eradication of Helicobacter pylori. Effect of pretreatment with omeprazole on the cure rate

Journal of Gastroenterology

Volumn 33, Issue 5, 1998, Pages 640-645

  Okada, Mitsuo ^a   Oki, Koichiro ^a   Shirotani, Takuro ^a   Seo, Mitsuru ^a   Okabe, Nobuo ^a   Maeda, Kazuhiro ^a   Nishimura, Hirokatsu ^a   Ohkuma, Kenji ^a   Oda, Kazuto ^a  

^a FUKUOKA UNIVERSITY   (Japan)

Author keywords

Eradication; Helicobacter pylori; Omeprazole; Quadruple therapy; Roxithromycin

Indexed keywords

AMOXICILLIN; METRONIDAZOLE; OMEPRAZOLE; ROXITHROMYCIN;

ABDOMINAL DISTENSION; ADULT; ALLERGIC REACTION; ANOREXIA; ANTIBIOTIC THERAPY; ARTICLE; DIARRHEA; DYSPEPSIA; ERADICATION THERAPY; FEMALE; FLATULENCE; GASTROSCOPY; GLOSSITIS; GRAM NEGATIVE INFECTION; HELICOBACTER PYLORI; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PEPTIC ULCER; PRIORITY JOURNAL; RASH; STOMATITIS; TIME; TREATMENT OUTCOME; VERTIGO;

ADULT; AGED; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-ULCER AGENTS; DRUG THERAPY, COMBINATION; DYSPEPSIA; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; METRONIDAZOLE; MIDDLE AGED; OMEPRAZOLE; PENICILLINS; PEPTIC ULCER; ROXITHROMYCIN; TREATMENT OUTCOME;

EID: 0031683452     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350050150     Document Type: Article

References (42)

1. Okabe H. Clinical course and prognosis of gastric ulcer. In: Yoshitoshi Y (ed) All aspects of gastric and duodenal ulcers (in Japanese). Tokyo: Nankodo, 1971;263-278.
2. Thomson ABR, Mahachai J. Medical management of uncomplicated peptic ulcer disease. In: Haubrich WS, Kalser MH, Roth JCA, Schaffner F (eds) Bockus gastroenterology. 4th ed. WB Saunders: 1985:1116-1154.
3. Sung JJY, Chung SCS, Ling TKW, et al. Antibacterial treatment of gastric ulcers associated with Helicobacter pylori. N Engl J Med 1995;332:139-142.
4. Hosking SW, Ling TKW, Chung SCS, et al. Duodenal ulcer healing by eradication of Helicobacter pylori without anti-acid treatment: Randomized controlled trial. Lancet 1994;343:508-510.
5. Shirotani T, Okada M, Murayama H, et al. Effect of the eradication of Helicobacter pylori on duodenal ulcer healing and ulcer relapse: Randomized controlled study in Japan. J Gastroenterol 1996;31:175-181.
6. Marshall BJ, Goodwin CS, Warren JR, et al. Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 1988;II:1437-1442.
7. Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer. A randomized controlled study. Ann Intern Med 1992;116:705-708.
8. Hentschell E, Brandstarter G, Dragosics G, et al. Effect of ranitidine and amoxicillin plus metronidazole on the eradication of Helicobacter pylori and the recurrence of duodenal ulcer. N Engl J Med 1993;328:308-312.
9. Labenz J, Borsch G. Evidence for the essential role of Helicobacter pylori in gastric ulcer disease. Gut 1994;35:19-22.
10. Tatsuta M, Iishi H, Yokota Y. Effects of Helicobacter pylori infection on healing and recurrence of gastric ulcers. Am J Gastroenterol 1995;90:406-410.
11. Tytgatt GNJ, Van der Hulse RWM. Important acquisitions in Helicobacter pylori infection. Curr Opin Gastroenterol 1995;11(Suppl 1):57-60.
12. Labenz J, Gyenns E, Runl GH, et al. Omeprazole plus amoxicillin: Efficacy of various treatment regimens to eradicate Helicobacter pylori. Am J Gastroenterol 1993;88:491-495.
13. Fukami T. Isolation, identification of Campylobacter pylori (in Japanese). Examination and Technology 1989;17:1389-1394.
14. Thys JC, van Zwet AA, Oey HB. Efficacy and side effects of a triple drug regimen for the eradication of H. pylori. Scand J Gastroenterol 1993;28:934-938.
15. Wassertheil-Smoller S. Biostatistics and Epidemiology. A primer for health professionals. 2nd ed. New York: Springer, 1995;27-84.
16. Adamek RJ, Freitag M, Opferkuch W, et al. Intravenous omeprazole/amoxicillin and omeprazole pretreatment in Helicobacter pylori-positive acute peptic ulcer bleeding. A pilot study. Scand J Gastroenterol 1994;29:880-883.
17. Zala G, Giezendanner S, Flury R, et al. Omeprazole/amoxicillin: beeintrachtigte Eradikation von Helicobacter pylori durch Rauchen, aber nicht durch eine Omeprazole-Varbehandlung. Schweiz Med Wochenschr 1994;124:1398-1404.
18. Moayyedi P, Chalmers PM, Axon ATR. Patients factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori. J Gastroenterol 1997;32:24-27.
19. de Boer WA. How to achiere a near 100% cure rate of H. pylori infection in peptic ulcer patients. A personal view point. J Clin Gastroenterol 1996;22:313-316.
20. de Boer WA, van Etten RJXM, Lai JYLL, et al. Effectiveness of quadruple therapy using lansoprazole, instead of omeprazole, in curing Helicobacter pylori infection. Helicobacter 1996;1:145-150.
21. Graham DY. A reliable cure for Helicobacter pylori infection? (personal viewpoint) Gut 1995;37:154-156.
22. Van der Hulst RWM, Keller JJ, Rauws EAJ, et al. Treatment of Helicobacter pylori infection: A review of the world literature. Helicobacter 1996;1:6-19.
23. de Boer WA, Tytgart CNJ. The best therapy for Helicobacter pylori infection: Should efficacy or side effect profile determine our choice? Scand J Gastroenterol 1995;30:401-407.
24. de Boer WA, Driessen WMM, Jansz AR, et al. Quadruple therapy compared with dual therapy for eradication of Helicobacter pylori in ulcer patients: Results of a randomized prospective single-centre study. Eur J Gastroenterol Hepatol 1995;7:1189-1194.
25. de Boer WA, Driessen WMM, Jansz AR, et al. Effect of acid suppression on efficacy of treatment for Helicobacter pylori infection. Lancet 1995;345:817-820.
26. Seppala K, Sipponee P, Nuntinen H, et al. Intent to treat metronidazole-resistam H. pylori infection to 100% of cure: Therapy with quadruple therapy and its modifications (abstract). Gastroenterology 1995;108:216.
27. de Boer WA, Tytgat GNJ. How to treat Helicobacter pylori infection - should treatment strategies be based on testing bacterial susceptibility? A personal viewpoint. Eur J Gastroenterol 1996;8:709-716.
28. Hirschl AM, Hirschl MM, Rotter ML. Comparison of three methods for the determination of the sensitivity of Helicobacter pylori to metronidazole. J Antimicrob Chemother 1993;32:45-49.
29. Hosking SW, Ling TKW, Yung MY, et al. Randomized controlled trial of short term treatment to eradicate H. pylori in patients with duodenal ulcer. BMJ 1992;305:502-504.
30. Borody TJ, Andrews P, Shortis NP, et al. Optimal H. pylori therapy: A combination of omeprazole and triple therapy (abstract). Gastroenterology 1994;106:55.
31. Borody TJ, Andrews P, Fracehia G, et al. Omeprazole enhances efficacy of triple therapy in eradicating Helicobacter pylori. Gut 1995;37:477-481.
32. Bell GD, Powell KU, Burridge SM, et al. Rapid eradication of H. pylori infection. Aliment Pharmacol Ther 1995;9:41-46.
33. Bazzoli F, Zagari RM, Fossi S, et al. Short term low-dose triple therapy for the eradication of H. pylori. Eur J Gastroenterol Hepatol 1994;6:773-777.
34. Itoh T, Shingaki M, Yanagawa T, et al. Susceptibility of clinical isolates of H. pylori to four antimicrobial agents by agar dilution method, disk diffusion method and E-test (abstract). Second meeting of the Japanese Research Society for Helicobacter pylori-Related Gastroduodenal Disease, 1996:74.
35. Kubota T, Sata R, Murakami K, et al. Resistance of Helicobacter pylori to antibiotics before and after new triple therapy (abstract). Second Meeting of the Japanese Research Society for Helicobacter pylori-Related Gastroduodenal Disease. 1996:38.
36. Stolzle L. Eradication of Helicobacter pylori. Effectiveness of a combination of ranitidine and metronidazole/roxithromycin. (English abstract). Fortschr Med 1994;112:363-364.
37. Hardy DJ, Hanson CW, Hensey DM, Susceptibility of Campylobacter pylori to macrolides and fluoroquinolones. J Antimicrob Chemother 1988;22:631-636.
38. O'Sullivan N, Wise R. Macrolide, lincosamide and streptogramin antibiotics. Currt Opin Infect Dis 1990;3:743-750.
39. Garcia-Rodriguez JA, Sanchez JEG, Garcia MIG, et al. In vitro activities of new oral β-lactams and macrolides against Campylobacter pylori. Antimicrob Agents Chemother 1989; 33:1650-1651.
40. De Boer WA, Van Etten RJ XM, Schade RWB, et al. Four-day lansoprazole quadruple therapy: A highly effective cure for Helicobacter pylori infection. Am J Gastroenterol 1996;91:1778-1782.
41. Goodwin CS, Mc Nulty CAM. Bacteriological and pharmacological basis for the treatment of Helicobacter pylori infection. In: Rathbone BJ, Heatly RV (eds) Helicobacter pylori and gastroduodenal disease. 2nd ed. Oxford: Blackwell Scientific, 1992:224-231.
42. Grayson ML, Eliopaulos GM, Ferraro MJ, et al. Effect of varying pH on the susceptibility of Campylobacter pylori to antimicrobial agents. Eur J Clin Microbiol Infect Dis 1989;8:888-889.